A 
Anhui Sunhere Pharmaceutical Excipients Co 300452.SZ · CNY
Health Care · Shenzhen · 🇨🇳 China
11.82
0.00%
Close of 9 Nov 2026, in CNY
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
At a glance
Figures in CNY, from our data supplier.
Revenue
CN¥942.8m
FY2016FY2025
Net income
CN¥176.6m
FY2016FY2025
Free cash flow
CN¥151.3m
FY2016FY2025
Shareholders' equity
CN¥1.01bn
FY2016FY2025
Income statement
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | CN¥942.8m | CN¥882.6m | CN¥839.3m | CN¥704.5m | CN¥616.7m | CN¥531.2m | CN¥464.1m | CN¥428.6m | CN¥339.4m | CN¥286.4m |
| Gross profit | CN¥299.4m | CN¥273.2m | CN¥265.3m | CN¥209.2m | CN¥177.8m | CN¥164.4m | CN¥169.5m | CN¥145.4m | CN¥104.9m | CN¥96.8m |
| Research and development | CN¥42.3m | CN¥41.0m | CN¥42.0m | CN¥34.4m | CN¥26.8m | CN¥18.1m | CN¥16.2m | CN¥14.2m | CN¥8.6m | CN¥8.0m |
| Operating income | CN¥210.8m | CN¥143.3m | CN¥188.8m | CN¥136.6m | CN¥99.7m | CN¥109.0m | CN¥103.7m | CN¥88.4m | CN¥60.8m | CN¥53.6m |
| Net income | CN¥176.6m | CN¥119.4m | CN¥161.5m | CN¥130.7m | CN¥89.3m | CN¥93.9m | CN¥84.4m | CN¥70.1m | CN¥50.3m | CN¥48.8m |
| Diluted earnings per share | 0.76 | 0.49 | 0.61 | 0.58 | 0.38 | 0.43 | 0.37 | 0.29 | 0.21 | 0.21 |
Balance sheet
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | CN¥1.71bn | CN¥1.56bn | CN¥1.54bn | CN¥1.18bn | CN¥962.6m | CN¥900.9m | CN¥810.2m | CN¥709.7m | CN¥666.4m | CN¥512.8m |
| Cash and short-term investments | — | CN¥708.3m | CN¥685.7m | CN¥364.7m | CN¥329.1m | CN¥300.5m | CN¥184.5m | CN¥87.5m | CN¥128.0m | CN¥117.4m |
| Total liabilities | CN¥639.2m | CN¥584.4m | CN¥607.5m | CN¥391.9m | CN¥256.7m | CN¥245.7m | CN¥213.6m | CN¥151.9m | CN¥166.2m | CN¥110.1m |
| Debt | CN¥309.2m | CN¥305.0m | CN¥297.6m | CN¥39.8m | CN¥31.0m | CN¥40.0m | CN¥11.1m | CN¥54.2m | CN¥64.2m | CN¥36.8m |
| Shareholders' equity | CN¥1.01bn | CN¥905.0m | CN¥866.1m | CN¥722.5m | CN¥640.0m | CN¥585.2m | CN¥525.8m | CN¥493.1m | CN¥441.5m | CN¥402.7m |
| Shares outstanding | 233m | 244m | 265m | 224m | 237m | 220m | 230m | 244m | 239m | 227m |
Cash flow
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | CN¥192.0m | CN¥118.3m | CN¥142.8m | CN¥132.8m | CN¥103.8m | CN¥85.6m | CN¥79.5m | CN¥74.8m | CN¥63.5m | CN¥55.3m |
| Capital spending | −CN¥40.7m | −CN¥27.9m | −CN¥54.9m | −CN¥67.3m | −CN¥31.5m | −CN¥21.1m | −CN¥59.8m | −CN¥81.8m | −CN¥25.1m | −CN¥15.3m |
| Free cash flow | CN¥151.3m | CN¥90.4m | CN¥87.9m | CN¥65.5m | CN¥72.3m | CN¥64.5m | CN¥19.6m | −CN¥7.0m | CN¥38.4m | CN¥40.1m |
| Dividends paid | −CN¥71.4m | −CN¥59.0m | −CN¥59.8m | −CN¥54.1m | −CN¥45.1m | −CN¥34.4m | −CN¥27.8m | −CN¥22.6m | −CN¥19.9m | −CN¥9.3m |
Latest quarters
By quarter end
| Jun 2026 | Mar 2026 | Dec 2025 | Sept 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sept 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | CN¥260.3m | CN¥261.4m | CN¥246.3m | CN¥225.7m | CN¥223.0m | CN¥247.9m | CN¥238.2m | CN¥194.4m |
| Gross profit | CN¥82.8m | CN¥84.4m | CN¥77.4m | CN¥69.8m | CN¥72.0m | CN¥80.2m | CN¥65.8m | CN¥56.9m |
| Operating income | CN¥51.9m | CN¥57.7m | CN¥47.6m | CN¥44.8m | CN¥55.5m | CN¥56.0m | CN¥3.7m | CN¥33.2m |
| Net income | CN¥49.1m | CN¥47.1m | CN¥44.0m | CN¥39.5m | CN¥45.9m | CN¥47.2m | −CN¥3.0m | CN¥26.9m |
| Diluted earnings per share | 0.21 | 0.20 | 0.19 | 0.17 | 0.20 | 0.20 | -0.01 | 0.11 |
| Cash from operations | — | — | — | CN¥28.0m | CN¥86.0m | −CN¥3.0m | — | −CN¥2.0m |
| Capital spending | −CN¥7.0m | −CN¥15.0m | −CN¥10.0m | −CN¥11.0m | −CN¥6.0m | −CN¥12.0m | −CN¥8.0m | −CN¥7.0m |
| Free cash flow | — | — | — | CN¥17.0m | CN¥80.0m | −CN¥15.0m | — | −CN¥9.0m |
| Total assets | CN¥1.79bn | CN¥1.76bn | CN¥1.71bn | CN¥1.63bn | CN¥1.60bn | CN¥1.59bn | CN¥1.56bn | CN¥1.56bn |
| Cash and short-term investments | — | — | — | CN¥728.3m | CN¥707.7m | CN¥696.3m | CN¥708.3m | CN¥629.8m |
| Debt | CN¥314.2m | CN¥311.7m | CN¥309.2m | CN¥126.4m | CN¥310.6m | CN¥316.7m | CN¥305.0m | CN¥316.8m |
| Shareholders' equity | CN¥1.03bn | CN¥1.05bn | CN¥1.01bn | CN¥962.9m | CN¥923.5m | CN¥952.5m | CN¥905.0m | CN¥909.4m |
Financial ratios
Data as of 21 Oct 2026
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | |
|---|---|---|---|---|---|---|
| Gross margin | 31.8% | 31.0% | 31.6% | 29.7% | 28.8% | 31.0% |
| Operating margin | 22.5% | 17.6% | 22.7% | 19.5% | 15.9% | 20.3% |
| Net margin | 18.7% | 13.5% | 19.2% | 18.6% | 14.5% | 17.7% |
| Return on equity | 17.5% | 13.2% | 18.7% | 18.1% | 13.9% | 16.1% |
| Return on assets | 10.3% | 7.7% | 10.5% | 11.1% | 9.3% | 10.4% |
| Free cash flow yield | — | 3.9% | — | — | — | — |
| Revenue growth | 6.8% | 5.2% | 19.1% | 14.2% | 16.1% | 14.5% |
| Earnings growth | 47.8% | -26.1% | 23.6% | 46.4% | -5.0% | 11.3% |
| Current ratio | 4.14x | 4.38x | 3.44x | 1.83x | 2.48x | 2.26x |
| Debt to equity | 0.31x | 0.34x | 0.34x | -0.01x | 0.05x | 0.07x |
| Equity ratio | 58.8% | 58.0% | 56.1% | 61.2% | 66.5% | 65.0% |
| Interest coverage | 16.12x | 11.83x | 44.23x | 85.48x | 61.52x | 104.77x |
| R&D as a share of sales | 4.5% | 4.6% | 5.0% | 4.9% | 4.3% | 3.4% |
| Buybacks as a share of market value | 4.2% | 8.1% | -18.4% | 5.7% | -7.9% | 4.3% |
Growth per year
Compound annual rate
| 3 years | 5 years | 10 years | |
|---|---|---|---|
| Revenue | 10.2% | 12.2% | 13.8% |
| Operating income | 15.6% | 14.1% | 16.0% |
| Net income | 10.5% | 13.4% | 14.8% |
Average margins
Over each period
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Gross margin | 31.4% | 31.1% | 30.8% | 31.7% |
| Operating margin | 19.4% | 20.2% | 19.7% | 19.7% |
| Net margin | 16.2% | 17.5% | 17.1% | 17.0% |
Valuation history
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings | 17.7 | 24.7 | 23.4 | 30.0 | 44.8 | 31.2 | 24.6 | 28.2 | 56.6 | 80.4 |
| Price to sales | 3.3 | 3.3 | 4.5 | 5.6 | 6.5 | 5.5 | 4.5 | 4.6 | 8.4 | 13.7 |
Dividends and splits
Per share, in the currency the company pays
Paid for 10 years. Last went ex-dividend on 10 Jun 2026.
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | |
|---|---|---|---|---|---|---|---|---|
| Paid in the year | 0.30 | 0.30 | 0.25 | 0.25 | 0.30 | 0.192 | 0.148 | 0.118 |
- 13-for-10 split · 26 May 2022
- 13-for-10 split · 28 May 2020
- 3-for-2 split · 22 Jun 2018
- 2-for-1 split · 3 Jun 2016
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.